Cardiac stem cells

Journal of Pathology

Volumn 197, Issue 4, 2002, Pages 468-478

  Goldring, Kirstin ^a   Partridge, Terence ^b   Watt, Diana ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adult somatic stem cells; Cardiomyocytes; Cellular cardiomyoplasty; Embryonic stem cells

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL; BONE MARROW CELL; CARDIOMYOPLASTY; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; DONOR; EMBRYO CELL; FETUS CELL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART PERFORMANCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; RAT; REVIEW; STEM CELL TRANSPLANTATION;

ADULT; ANIMALS; BONE AND BONES; CARDIOMYOPLASTY; CELL DIFFERENTIATION; EMBRYO; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; STEM CELLS;

EID: 0036067957     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1159     Document Type: Review

References (109)

1. Current status of cardiac transplantation
2. Ventricular enlargement and remodeling following acute myocardial infarction: Mechanisms and management
3. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
4. Programmed myocyte cell death affects the viable myocardium after infarction in rats
5. Can grafted cardiomyocytes colonize peri-infarct myocardial areas?
6. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?
7. Survival, integration, and differentiation of cardiomyocyte grafts. A study in normal and injured rat hearts
8. Cardiomyocyte transplantation improved heart function
9. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium
10. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction
11. Smooth muscle cell transplantation into myocardial scar tissue improves heart function
12. Cardiomyocyte transplantation in a porcine myocardial infarction model
13. Long-term survival of AT-1 cardiomyocte grafts in syngeneic myocardium
14. Myoblast transplantation in the porcine model: A potential technique for myocardial repair
15. Construction of a bioengineered cardiac graft
16. Autologous heart cell transplantation improves cardiac function after myocardial injury
17. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts
18. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation
19. Cell transplantation for myocardial repair: An experimental approach
20. Myoblast cell grafting into heart muscle: Cellular biology and potential applications
21. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts
22. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats
23. Flk 1-positive cells derived from embryonic stem cells serve as vascular progenitors
24. Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages
25. The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications
26. Autologous transplantation of bone marrow cells improves damaged heart function
27. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart
28. Transplanted adult bone marrow cells repair myocardial infarcts in mice
29. Bone marrow cells regenerate infarcted myocardium
30. Mobilized bone marrow cells repair the infarcted heart, improving function and survival
31. Stem cell plasticity in muscle and bone marrow
32. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
33. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
34. Isolation of putative progenitor endothelial cells for angiogenesis
35. Evidence for circulating bone marrow-derived endothelial cells
36. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
37. The satellite cell: A review
38. Development of a novel method for cell transplantation through the coronary artery
39. Isolation and characterization of human muscle cells
40. Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case
41. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting
42. Myocyte transplantation for myocardial repair: A few good cells can mend a broken heart
43. Cellular cardiomyoplasty: Myocardial regeneration with satellite cell implantation
44. Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: Long-term survival and phenotypic modification of implanted myoblasts
45. Relationship of calcium transients to calcium currents and charge movements in myotubes expressing skeletal and cardiac dihydropyridine receptors
46. Cardiac-type excitation-contraction coupling in dysgenic skeletal muscle injected with cardiac dihydropyridine receptor cDNA
47. Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart
48. Embryonic stem cells: A model to study structural and functional properties in cardiomyogenesis
49. Establishment in culture of pluri-potential stem cells from mouse embryos
50. Effect of steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture
51. Long-term proliferation of mouse primordial germ cells in culture
52. Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryo toxicity studies: Present state and future prospects
53. Potential of embryonic stem cells
54. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types
55. Modulation of sarcomere organization during embryonic stem cell-derived cardiomyocyte differentiation
56. Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro
57. Selection of ventricular-like cardiomyocytes from ES cells in vitro
58. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes
59. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor
60. Derivation of pluripotent stem cells from cultured human primordial germ cells
61. Embryonic stem cell lines derived from human blastocyts
62. Embryonic stem cell lines from human blastocyts: Somatic differentiation in vitro
63. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes
64. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture
65. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice
66. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
67. Bone marrow as a potential source of hepatic oval cells
68. Liver from bone marrow in humans
69. Recruitment of bone marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice
70. Muscle regeneration by bone marrow-derived myogenic progenitors
71. Transplant-ability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
72. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow
73. Haematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice
74. Turning brain into blood: A haematopoeitic fate adopted by adult neural stem cells in vivo
75. Characterization of cells with osteogenic potential from human marrow
76. Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo
77. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone
78. Multilineage potential of adult human mesenchymal stem cells
79. Marrow stromal cells as stem cells for nonhaematopoietic tissues
80. Cardiomyocytes can be generated from marrow stromal cells in vitro
81. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to S-azacytidine
82. Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors
83. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering
84. Dystrophin expression in the mdx mouse restored by stem cell transplantation
85. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo
86. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
87. Survey of studies examining mammalian cardiomyocyte DNA synthesis
88. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice
89. DNA content, apoptosis and mitosis in transplanted human hearts
90. Proliferating cell nuclear antigen (PCNA), DNA synthesis and mitosis in myocytes following cardiac transplantation in man
91. Myocyte proliferation in end-stage cardiac failure in humans
92. Ventricular myocytes are not terminally differentiated in the adult mammalian heart
93. Myocyte cellular hyperplasia and myocyte cellular hypetrophy contribute to chronic ventricular modelling in coronary artery narrowing-induced cardiomyopathy in rats
94. Telomerase activity in rat cardiac myocytes is age and gender dependent
95. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart
96. Evidence that human cardiac myocytes divide after myocardial infarction
97. Chimerism of the transplanted heart
98. Systemic chimerism in human female recipients of male livers
99. An examination of tissue chimerism in the ACI to Lewis rat cardiac transplant model
100. Active cell migration in retransplanted rat cardiac allografts during the course of chronic rejection
101. Origin of neointimal and α-actin-positive smooth muscle cells in transplant arteriosclerosis
102. The use of fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections for the study of microchimerism
103. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation
104. Stem cells: A new lease on life
105. Adult-derived stem cells from the liver become myocytes in the heart in vivo
106. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion
107. Changing potency by spontaneous fusion
108. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use
109. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep